WVE-007 is a novel, long-acting GalNAc-siRNA targeting INHBE mRNA – a genetically validated target that provides a new ...

A critical flaw in millions of Apple products including Macs and iPads could allow attackers to execute code. Here's what you ...

NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF), a clinical-stage biotech company dedicated to developing neurorestorative therapeutics, today announced that the first subject has been enrolled and ...

Certain tumor types do not remain at their point of origin but spread throughout the body and form metastases. This is ...

A repository of proof-of-concept files demonstrating disclosed and patched vulnerabilities in pngcheck (2.4.0 - 3.0.1), including CVE-2020-27818, CVE-2020-35511 and other vulns. A collection of ...

Prime Medicine, Inc. faces risks in the gene editing sector despite positive developments, caution advised for retail investors. Click for my PRME stock update.

Professor Simon Stellmer from the University of Bonn receives a ‘Proof of Concept Grant’ from the European Research Council (ERC) for his project „GyroRevolutionPlus“. With the funding of €150,000 for ...

Hebrew University and Bar-Ilan University researchers secure grants to promote their breakthrough medical and scientific ...

UBS is taking a major step in integrating blockchain technology into traditional finance by experimenting with digital gold ...

Allosteric GABAA-receptor modulator AP-325 showed rapid onset as well as long-lasting pain reduction in patients with chronic neuropathic pain in Phase 2a study Data confirm previously reported ...

More than 100 projects have received support as part of the 2024 European Research Council (ERC) proof of concept competition ...